INHIBITION OF BACLOFEN-INDUCED HYPOTHERMIA IN MICE BY THE NOVEL GABA-B ANTAGONIST CGP 35348

被引:22
作者
JACKSON, HC
NUTT, DJ
机构
[1] Reckitt and Colman Psychopharrmcology Unit, School of Medical Sciences, Bristol, BS8 1TD England, University Walk
关键词
CGP; 35348; SELECTIVE GABA-B ANTAGONIST; GABA-B RECEPTORS; BACLOFEN; BODY TEMPERATURE;
D O I
10.1016/0028-3908(91)90018-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study shows that the selective GABA(B) antagonist CGP 35348 had no effect on body temperature in mice in doses up to 300 mg/kg i.p. However, the highest dose abolished the hypothermia induced by the GABA(B) agonist baclofen (10 mg/kg i.p.) but not that produced by the GABA-mimetic progabide (200 mg/kg i.p.); the benzodiazepine agonist loprazolam (3 mg/kg i.p.); the alpha-2-agonist UK 14,304 (1 mg/kg i.p.) nor the mu-opioid agonist morphine (30 mg/kg i.p.). These findings, showing selective antagonism of GABA(B) receptors by CGP 35348, confirm that this compound may be a valuable tool for exploration of GABA(B) receptor function in vivo.
引用
收藏
页码:535 / 538
页数:4
相关论文
共 9 条
[1]  
BITTINGER H, 1989, 1ST P ITN GABAB S CA
[2]   GABAB RECEPTORS AND THEIR SIGNIFICANCE IN MAMMALIAN PHARMACOLOGY [J].
BOWERY, N .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (10) :401-407
[3]   (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL ;
DOBLE, A ;
MIDDLEMISS, DN ;
SHAW, J ;
TURNBULL, M .
NATURE, 1980, 283 (5742) :92-94
[5]   HYPOTHERMIA INDUCED BY BACLOFEN, A POSSIBLE INDEX OF GABA-B RECEPTOR FUNCTION IN MICE, IS ENHANCED BY ANTIDEPRESSANT DRUGS AND ECS [J].
GRAY, JA ;
GOODWIN, GM ;
HEAL, DJ ;
GREEN, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :863-870
[6]  
JOHNS TG, 1979, ARCH INT PHARMACOD T, V240, P53
[7]  
LLOYD KG, 1982, J PHARMACOL EXP THER, V220, P672
[8]  
PAUL SM, 1981, BIOL PSYCHIAT, V16, P213
[9]   A BENZODIAZEPINE AGONIST AND CONTRAGONIST HAVE HYPOTHERMIC EFFECTS IN RODENTS [J].
TAYLOR, SC ;
LITTLE, HJ ;
NUTT, DJ ;
SELLARS, N .
NEUROPHARMACOLOGY, 1985, 24 (01) :69-73